Dalvi RR et al., 1991: Study in rats, mice and chickens finding no change in hepatic drug-metabolising enzymes after five days of fenbendazole at 10 mg/kg, and no in vitro binding to or inhibition of cytochrome P-450.
In vitro studies also indicate that fenbendazole does not interact with the hepatic microsomal monooxygenase system, indicating it is not a substrate for cytochrome P-450-dependent monooxygenase system.
Dalvi RR et al., 1991: Study in rats, mice and chickens finding no change in hepatic drug-metabolising enzymes after five days of fenbendazole at 10 mg/kg, and no in vitro binding to or inhibition of cytochrome P-450. Animal and in vitro study; rats, mice and chickens; United States (Tuskegee University); fenbendazole 10 mg/kg intraperitoneally daily for 5 days, plus in vitro microsome incubations. Funder: NIH/NCRR grant 5G12RR03059. Declared conflicts: none recorded. Comparator: vehicle-treated controls. Bearing CONTRADICTS a blanket statement that fenbendazole induces or inhibits CYP enzymes: at 10 mg/kg by the intraperitoneal route in these three species it did neither. The positive findings in this record (CYP1A induction in pigs at in-feed doses, P450 inhibition by metabolites in rat microsomes) involve higher or repeated exposure and different routes, so the two results are compatible but the contradiction must be stated rather than smoothed over. The title as indexed contains a typographical error ('in vitro and in vitro').
